Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug 22;500(7463):486-9.
doi: 10.1038/nature12327. Epub 2013 Jul 14.

Structural basis for molecular recognition of folic acid by folate receptors

Affiliations

Structural basis for molecular recognition of folic acid by folate receptors

Chen Chen et al. Nature. .

Abstract

Folate receptors (FRα, FRβ and FRγ) are cysteine-rich cell-surface glycoproteins that bind folate with high affinity to mediate cellular uptake of folate. Although expressed at very low levels in most tissues, folate receptors, especially FRα, are expressed at high levels in numerous cancers to meet the folate demand of rapidly dividing cells under low folate conditions. The folate dependency of many tumours has been therapeutically and diagnostically exploited by administration of anti-FRα antibodies, high-affinity antifolates, folate-based imaging agents and folate-conjugated drugs and toxins. To understand how folate binds its receptors, we determined the crystal structure of human FRα in complex with folic acid at 2.8 Å resolution. FRα has a globular structure stabilized by eight disulphide bonds and contains a deep open folate-binding pocket comprised of residues that are conserved in all receptor subtypes. The folate pteroate moiety is buried inside the receptor, whereas its glutamate moiety is solvent-exposed and sticks out of the pocket entrance, allowing it to be conjugated to drugs without adversely affecting FRα binding. The extensive interactions between the receptor and ligand readily explain the high folate-binding affinity of folate receptors and provide a template for designing more specific drugs targeting the folate receptor system.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1. Structure of FRα bound to folic acid
a, Two views of the complex, with FRα in green, folic acid in grey, NAG in orange and the disulphide bonds depicted as yellow sticks. The N and C termini are labelled. b, Ribbon diagram of FRα, with folic acid and NAG in green stick presentations, overlaid with the semi-transparent receptor surface. c, Charge distribution surface of FRα with a close-up view of the ligand-binding pocket entrance. Folic acid carbon atoms are coloured grey, nitrogen atoms blue, and oxygen atoms red. A colour-code bar (bottom) shows an electrostatic scale from −3 to +3 eV.
Figure 2
Figure 2. Structural and biochemical analysis of FRα–folic acid interactions
a, The σA-weighted 2Fo – Fc electron density map for folic acid, shown as a grey mesh. b, The internal charge distribution surface of the binding pocket is shown using the same colour code as in Fig. 1c, with folic acid shown in stick presentation. c, Folic acid-binding network with close-ups of the folic acid head and tail groups. Residues that line the binding pocket are shown in green and folic acid is shown in grey. Hydrogen bonds are indicated by dashed lines.
Figure 3
Figure 3. Folic acid affinities of FRα ligand-binding-pocket mutants
a, Interaction map of folic acid with ligand-binding-pocket residues. The folic acid chemical structure is shown in magenta, pocket residues in black and hydrogen bonds as green dashed lines with bond distances (Å) indicated. Hydrophobic interactions are presented as curved red lines. The pteroate and glutamate moieties of folic acid are indicated above the map. b, Folic acid affinities of wild-type and mutant FRα proteins as measured by [3H]-folic acid binding assay (see Supplementary Figs 7 and 8 for binding isotherms). The numbers on top of the bars indicate the fold decrease in affinity (increase in Kd) relative to wild-type FRα. Error bars indicate s.d. (n –2).

References

    1. Kelemen LE. The role of folate receptor α in cancer development, progression and treatment: cause, consequence or innocent bystander? Int J Cancer. 2006;119:243–250. - PubMed
    1. Kane MA, et al. Influence on immunoreactive folate-binding proteins of extracellular folate concentration in cultured human-cells. J Clin Invest. 1988;81:1398–1406. - PMC - PubMed
    1. Matsue H, et al. Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate. Proc Natl Acad Sci USA. 1992;89:6006–6009. - PMC - PubMed
    1. McGuire JJ. Anticancer antifolates: current status and future directions. Curr Pharm Des. 2003;9:2593–2613. - PubMed
    1. Deng YJ, et al. Synthesis and biological activity of a novel series of 6-substituted thieno 2,3-d pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate transporter for cellular entry. J Med Chem. 2009;52:2940–2951. - PMC - PubMed

Publication types

Associated data